v3.19.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2018
Dec. 31, 2017
Current Assets:    
Cash and cash equivalents $ 18,417,513 $ 185,151
Accounts receivable and other receivables, net 168,169 227,918
Inventory, net 1,235,334 247,466
Current portion of operating lease right-of-use asset 168,595
Prepaid expenses and other current asset 839,520 108,352
Total Current Assets 20,829,131 768,887
Property and equipment, net 383,567 376,920
Operating lease right-of-use asset, non-current portion 270,713
Intangible assets, net 95,852 106,167
Deferred public offering costs 1,367,730
Other assets 71,198 67,309
Total Assets 21,650,461 2,687,013
Current Liabilities:    
Accounts payable 1,420,178 4,228,073
Accrued expenses 2,706,939 23,135,344
Accrued issuable equity 318,493 2,939,906
Derivative liabilities 3,448,390
Current portion of convertible notes payable 50,000
Convertible notes payable - related party 747,567
Notes payable 287,966 597,966
Current portion of operating lease liabilities 151,997
Current portion of deferred revenue 357,048 383,771
Total Current Liabilities 5,242,621 35,531,017
Convertible notes payable, non-current portion, net of debt discount of $0 and $499,435 as of December 31, 2018 and 2017, respectively 3,200,096
Operating lease liabilities, non-current portion 299,733
Deferred revenue, non-current portion 13,878 50,283
Total Liabilities 5,556,232 38,781,396
Series B Convertible Preferred Stock, 10,000 shares designated, 0 and 8,250 issued and outstanding as of December 31, 2018 and 2017, respectively 825,000
Commitments and contingencies
Stockholders' Equity (Deficiency):    
Common stock, $0.001 par value, 500,000,000 shares authorized, 26,118,075 and 5,523,673 shares issued and outstanding as of December 31, 2018 and 2017, respectively 26,118 5,524
Additional paid-in capital 175,924,587 119,499,141
Accumulated deficit (159,856,481) (156,435,278)
Total Stockholders' Equity (Deficiency) 16,094,229 (36,919,383)
Total Liabilities and Stockholders' Equity (Deficiency) 21,650,461 2,687,013
Series A Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 11,000
Series C Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; 230
Series D Convertible Preferred Stock [Member]    
Stockholders' Equity (Deficiency):    
Preferred stock, $0.001 par value, 40,000,000 shares authorized; $ 5

Source